Embecta Corp. (EMBC)
After hours:
| Previous Close | 10.23 |
| Open | 10.43 |
| Bid | 10.11 x 600 |
| Ask | 10.17 x 300 |
| Day's Range | 10.12 - 10.56 |
| 52 Week Range | 9.93 - 32.00 |
| Volume | |
| Avg. Volume | 434,516 |
| Market Cap | 589.608M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | 10.57 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.60 (5.91%) |
| Ex-Dividend Date | Feb 27, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
embecta to Participate in Investor Events
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events: 2024 BofA Securities Healthcare Conference Management will host a fireside session on Thursday, May 16, 2024, at 10:00 a.m. Pacific Time (PT) at the Encore Hotel in Las Vegas. Audio webcasts of the presentations will be accessible under the “News &
- GlobeNewswire
embecta to Report Fiscal Second Quarter 2024 Financial Results
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, May 9, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live
- GlobeNewswire
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference. This event is scheduled for Wednesday, March 6, at 10:40 a.m. Eastern Standard Time / 14:40 Central European Time. Additionally, six embecta-sponsored abstracts focusing on injection and insulin
